Physician profile
Sameer Arora
NPI 1851688410
$4,665.64
in general payments reported to CMS, 2019-2025
23 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.68 · 2021: $339 · 2022: $377 · 2023: $1,787 · 2024: $982 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,765 · Travel and Lodging: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,765.07 |
| Travel and Lodging | $1,167.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,692.61 | 2020-2025 | Avvigo Guidance System, Neuroblate Robotic Probe Driver, Watchman Access System |
| Abbott Laboratories | $667.14 | 2023-2025 | Esprit, Diamondback Peripheral, Optis |
| Amgen INC. | $400.92 | 2024-2025 | Repatha |
| Shockwave Medical, INC | $335.58 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $297.70 | 2021-2023 | Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $279.77 | 2024-2025 | |
| Chiesi USA, INC. | $162.66 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $151.41 | 2022-2025 | Lifevest |
| Penumbra, INC. | $103.13 | 2024 | Indigo System |
| W. L. Gore & Associates, INC. | $87.64 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Imperative Care, INC | $82.09 | 2025 | Symphony Catheter |
| Janssen Pharmaceuticals, INC | $69.20 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $58.98 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Cathworks, INC. | $44.96 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.85 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $41.50 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.00 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $21.59 | 2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $21.54 | 2024 | Wainua |
| Recor Medical INC | $21.39 | 2025 | Paradise Ultrasound Renal Denervation System |
| Kiniksa Pharmaceuticals, LTD. | $16.85 | 2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $15.82 | 2024 | Eliquis |
| Terumo Medical Corporation | $13.31 | 2024 | Azur Cx Detachable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.